Computational tools for structure-based ligand design

Progress in Biophysics and Molecular Biology

Volumn 66, Issue 3, 1996, Pages 197-210

  Böhm, Hans Joachim ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPLEX FORMATION; COMPUTER ASSISTED DESIGN; COMPUTER PROGRAM; DATA BASE; DRUG DESIGN; LIGAND BINDING; PROTEIN BINDING; PROTEIN STRUCTURE; SCORING SYSTEM; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

EID: 0030409818     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0079-6107(97)00005-9     Document Type: Review

References (106)

1. Allen, F. H., Davies, J. E. and Galloy, J. J. et al. (1991). The development of versions 3 and 4 of the Cambridge structural database system. J. Chem. Inf. Comput. Sci. 31, 187-204.
2. Ajay and Murcko, M. A. (1995). Computational methods to predict binding free energy in ligand-receptor complexes. J. med. Chem. 38, 4953-4967.
3. Babine, R. E., Bleckman, T. M., Kissinger, C. R., Showalter, R., Pelletier, L. A., Lewis, C., Tucker, C., Moomaw, E., Parge, H. E. andVillafranca, J. E. (1995) Design, synthesis and X-ray crystallographic studies of novel FKBP-12 ligands. Bioorg. med. Chem. Lett. 5, 1719-1724.
4. Baldwin, J. J., Ponticello, G. S., Anderson, P. S., Christy, M. E., Murcko, M. A., Randall, W. C., Schwam, H., Sugrue, M. F., Springer, J. P., Gautheron, P., Grove, J., Mallorga, P., Viader, M. P., McKeever, B. M. and Navia, M. A. (1989). Thienothiopyran-2-sulfonamides: Novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J. med. Chem. 32, 2510-2513.
5. Balkenhohl, F., von dem Busche-Hünnefeld, C., Lansky, A. and Zechel, C. (1996). Combinatorial synthesis of small organic molecules. Angew. Cem. Int. Ed. Engl. 35, 2288-2337.
6. Banner, D., Ackermann, J., Gast, A., Gubernator, K., Hadvary, P., Hilpert, K., Labler, L., Müller, K., Schmid, G., Tschopp, T., van de Waterbeemd, H. and Wirz, B., (1993) Serine proteases: 3D structures, mechanisms of action and inhibitors. In Perspectives in Medicinal Chemistry, pp. 27-43 (eds. B. Testa, R. Giger, E. Kyburz and W. Fuhrer). VCH, Weinheim.
7. Bash, P., Singh, U. C., Brown, F. K., Langridge, R. and Kollman, P. A. (1987). Calculation of the relative change in binding free energy of a protein-inhibitor complex. Science 235, 574-576.
8. Blaney, J. M. and Dixon, J. S. (1993) A good ligand is hard to find: Automated docking methods. Persp. Drug Disc. Des. 1, 301-319.
9. Bohacek, R. S. and McMartin, C. (1992) Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: Validation of a high resolution graphical tool for drug design. J. med. Chem. 35, 1671-1684.
10. Bohacek, R. S. and McMartin, C. (1994) Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of a de novo design method incorporating combinatorial growth. J. Am. Chem. Soc. 116, 5560-5571.
11. Bohacek, R. S., McMartin, C. and Guida, W. C. (1996) The art and practice of structure-based drug design. Med. Res. Rev. 16, 3-50.
12. Böhm, H. J. (1992) The computer program LUDI: A new method for the de novo design of enzyme inhibitors. J. Computer-aided Molec. Des. 6, 61-78.
13. Böhm, H. J. (1992) LUDI: Rule-based automatic design of new substituants for enzyme inhibitor leads. J. Computer-aided Molec. Des. 6, 593-606.
14. Böhm, H. J. (1993) Ligand design. In 3D QSAR in Drug Design, pp. 386-405 (ed. H. Kubinyi). Escom, Leiden.
15. Böhm, H. J. (1994a) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J. Computer-aided Molec. Des. 8, 243-256.
16. Böhm, H. J. (1994b) On the use of LUDI to search the find chemicals directory for ligands of proteins of known three-dimensional structure. J. Computer-aided Molec. Des. 8, 623-632.
17. Böhm, H. J. (1995) Site-directed structure generation by fragment-joining. Persp. Drug Disc. Des. 3, 21-33.
18. Böhm, H. J. (1996a) Towards the automatic design of sythetically accessible protein ligands: Peptides, amides and peptidomimetics. J. Computer-aided Molec. Des. 10, 265-272.
19. Böhm, H. J. (1996b) Current computational tools for de novo ligand design. Curr. Opin. Biotech 7, 433-436.
20. Böhm, H. J. (1996c) Combinatorial docking, In Computer-assisted Lead Finding and Optimization, Proceedings of the 11th European Symposium on Quantitative Structure-Activity Relationships, (ed. H. van de Waterbeemd). (In press).
21. Böhm, H. J. and Klebe, G. (1996) What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Angew. Chem. Int. Ed. Engl. 35, 2588-2614.
22. Boobbyer, D. N. A., Goodford, P. J., McWhinnie, P. M. and Wade, R. C. (1989) New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure. J. med. Chem. 32, 1083-1094.
23. Brooks, C. L., Karplus, M. and Pettitt, B. M. (1988) Proteins: A Theoretical Perspective of Dynamics, Structure and Thermodynamics. J. Wiley, New York.
24. Caflish, A. and Karplus, M. (1995) Computational combinatorial chemistry for de novo ligand design: Review and assessment. Persp. Drug Disc. Des. 3, 51-84.
25. Cohen, N. C., Blaney, J. M., Humblet, C., Gund, P. and Barry, D. C. (1990) Molecular modeling software and methods for medicinal chemistry. J. med. Chem. 33, 883-894.
26. Connolly, M. L. (1992) Shape distributions of protein topography. Biopolymers 32, 1215-1236.
27. Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., Spellmeyer, D. C., Fox, T., Caldwell, J. W. and Kollman, P. A. (1995) J. Am. Chem. Soc. 117, 5179-5197.
28. Cramer, C. J. and Truhlar, D. G. (1991) General parameterized SCF model for free energies of solvation in aqueous solution. J. Am. Chem. Soc. 113, 8305-8311.
29. DesJarlais, R. L., Sheridan, R. P., Seibel, G. L., Dixon, J. S., Kuntz, I. D. and Venkataraghavan, R. (1988) Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J. med. Chem. 31, 722-729.
30. Edwards, P. D., Andisik, D. W., Strimpler, A. M., Gomes, B. and Tuthill, P. A. (1996) Nonpeptidic inhibitors of human neutrophil elastase. 7. Design, synthesis, and in vitro activity of a series of pyridopyrimidine trifluoromethyl ketones. J. med. Chem. 39, 1112-1124.
31. Gehlhaar, D. K., Moerder, K. E., Zichi, D., Sherman, C. J., Ogden, R. C. and Freer, S. T. (1995a) De novo design of enzyme inhibitors by Monte Carlo ligand generation. J. med. Chem. 38, 466-472.
32. Gehlhaar, D. K., Verkhivker, G. M., Rejto, P. A., Sherman, C. J., Fogel, D. B. and Freer, S. T. (1995b) Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming. Chemistry and Biology 2, 317-324.
33. Gerber, P. R. and Müller, K. (1995) MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J. Computer-aided Molec. Des. 9, 251-268.
34. Goodford, P. J. (1985) A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. med. Chem. 28, 849-857.
35. Greer, J., Erickson, J. W., Baldwin, J. J. and Varney, M. D. (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. J. med. Chem. 37, 1035-1054.
36. Grootenhuis, P. D. J. and Van Galen, P. J. M. (1995) Correlation of binding affinities with non-bonded interaction energies of thrombin-inhibitor complexes. Acta Cryst. D51, 560-566.
37. Gschwend, D. A., Good, A. C. and Kuntz, I. D. (1996) Molecular docking towards drug discovery. J. Mol. Recogn. 9, 175-186.
38. Halgren, T. (1992) Representation of van der Waals (vdW) interactions in molecular mechanics force fields: Potential form, combination rules, and vdW parameters. J. Am. Chem. Soc. 114, 7827-7843.
39. Hilpert, K., Ackermann, J., Banner, D. W., Gast, A., Gubernator, K., Hadvary, P., Labler, L., Müller, K., Schmid, G., Tschopp, T. B. and van de Waterbeemd, H. (1994) Design and synthesis of potent and highly selective thrombin inhibitors. J. med. Chem. 37, 3889-3901.
40. Holloway, M. K., Wai, J. M., Halgren, T. A., Fitzgerald, P. M. D., Vacca, J. P., Dorsey, B. D., Levin, R. B., Thompson, W. J., Chen, L. J., DeSolms, S. J., Gaffin, N., Ghosh, A. K., Giuliani, E. A., Graham, S. L., Guare, J. P., Hungate, R. W., Lyle, T. A., Saunders, W. M., Tucker, T. J., Wiggins, M., Wiscount, C. M., Woltersdorf, O. W., Young, S. D., Darke, P. L. and Zugay, J. A. (1995) A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. J. med. Chem. 38, 305-317.
41. Honig, B. and Nicholls, A. (1995) Classical electrostatics in biology and chemistry. Science 268, 1144-1149.
42. Horton, N. and Lewis, M. (1992) Calculation of the free energy of association for protein complexes. Prot. Sci. 1, 169-181.
43. Jones, G., Willett, P. and Glen, R. C. (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of solvation. J. molec. Biol. 245, 43-53.
44. Jorgensen, W. L. and Tirado-Rives, J. (1988) The OPLS potential functions for proteins. Energy minimizations for crystals of cyclic peptides and crambin. J. Am. Chem. Soc. 110, 1657-1666.
45. Kang, Y. K., Gibson, K. D., Nemethy, G. and Scheraga, H. A. (1988) Free energies of hydration of solute molecules. 4. Revised treatment of the hydration shell model. J. Phys. Chem. 92, 4739-4742.
46. Kellog, G. E., Joshi, G. S. and Abraham, D. J. (1992) New tools for modeling and understanding hydrophobicity and Hydrophobic interactions. Med. Chem. Res. 1, 444-453.
47. Klebe, G. (1994) The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. J. molec. Biol. 237, 212-235.
48. Kleywegt, G. J. and Jones, T. A. (1994) Detection, deliniation, measurement and display of cavities in macromolecular structures. Acta Cryst. D50, 178-185.
49. Kollman, P. A. (1993) Free energy calculations: Application to chemical and biochemical phenomena. Chem. Rev. 93, 2395-2417.
50. Kuntz, I. D. (1992) Structure-based strategies for drug design and discovery. Science 257, 1078-1082.
51. Kuntz, I. D., Meng, E. C. and Shoichet, B. K. (1994) Structure-based molecular design. Acc. Chem. Res. 27, 117-123.
52. Krystek, S., Stouch, T. and Novotny, J. (1993) Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures. J. molec. Biol. 234, 661-679.
53. Lam, P. Y. S., Jadhav, P. K., Eyermann, C. J., Hodge, C. N., Ru, Y., Bacheler, L. T., Meek, J. L., Otto, M. J., Rayner, M. M., Wong, Y. N., Chang, C. H., Weber, P. C., Jackson, D. A., Sharpe, T. R. and Erickson-Viitanen, S. (1994) Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 262, 380-384.
54. Lawrence, M. C. and Davis, P. C. (1992) CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three-dimensional structure. Proteins 12, 31-41.
55. Leach, A. R. (1994) Ligand docking to proteins with discrete side-chain flexibility. J. molec. Biol. 235, 345-356.
56. Lewis, R. A. (1989) Determination of clefts in receptor structures. J. Computer-aided Molec. Des. 3, 133-147.
57. Lewis, R. A. and Leach, A. (1994) Current methods for site-directed structure generation. J. Computer-aided Molec. Des. 8, 467-475.
58. Mack, H., Pfeiffer, T., Hornberger, W., Böhm, H. J. and Höffken, H. W. (1995) Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin. J. Enz. Inhib. 9, 73-86.
59. Maple, J. R., Hwang, M. J., Stockfisch, T. P., Dinur, U., Waldman, M., Ewig, C. and Hagler, A. T. (1994) J. Comput. Chem. 15, 162-182.
60. Martin, Y. C. (1992) 3D database searching in drug design. J. med. Chem. 35, 2145-2154.
61. Mata, P., Gillet, V. J., Johnson, P., Lampreia, J., Myatt, G. J., Sike, S. and Stebbings, A. L. (1995) SPROUT: 3D structure generation using templates. J. Chem. Inf. Comput. Sci. 35, 479-493.
62. McCammon, J. A. and Harvey, S. C. (1987) Dynamics of Proteins and Nucleic Acids. Cambridge University Press, Cambridge.
63. Melnick, M., Reich, S. H., Lewis, K. K., Mitchell, L. J., Nguyen, D., Trippe, A. J., Dawson, H., Davies II, J. F., Appelt, K., Wu, B. W., Musick, L., Gehlhaar, D. K., Webber, S., Shetty, B., Kosa, M., Kahil, D. and Andrada, D. (1996) Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design. J. med. Chem. 39, 2795-2811.
64. Meng, E. C., Shoichet, B. K. and Kuntz, I. D. (1992) Automated docking with grid-based energy evaluation. J. comp. Chem. 13, 505-524.
65. Meng, E. C., Gschwend, D. A., Blaney, J. M. and Kuntz, I. D. (1993) Orientational sampling and rigid-body minimization in molecular docking. Proteins 17, 266-278.
66. Merz, K. M., Murcko, M. A. and Kollman, P. A. (1991) Inhibition of carbonic anhydrase. J. Am. Chem. Soc. 113, 4484-4490.
67. Meyer, E. F., Botos, I., Scapozza, L. and Zhang, D. (1995) Backward binding and other structural surprises. Persp. Drug Discov. Des. 3, 168-195.
68. Mikol, V., Papgeorgiou, C. and Borer, X. (1995) The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: Synthesis, biological activity, and crystallographic analysis with cyclophilin A. J. med. Chem. 38, 3361-3367.
69. Miller, M. D., Kearsley, S. K., Underwood, D. J. and Sheridan, R. P. (1994) FLOG: A system to select "quasi-flexible" ligands complementary to a receptor of known three-dimensional structure. J. Computer-aided Molec. Des. 8, 153-174.
70. Miranker, A. and Karplus, M. (1991) Functionality maps of binding sites: A multiple copy simultaneous search method. Proteins: Struct. Funct. Genet. 11, 29-34.
71. Miyamoto, S. and Kollman, P. A. (1993) What determines the strength of noncovalent association of ligands to proteins in aqueous solution? Proc. natn. Acad. Sci. U.S.A. 90, 8402-8406.
72. Moon, J. B. and Howe, W. J. (1991) Computer design of bioactive molecules: A method for receptor-based de novo ligand design. Proteins: Struct. Funct. Genet. 11, 314-328.
73. Morton, A. and Matthews, B. W. (1995) Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: Linkage of dynamics and structural plasticity. Biochemistry 34, 8576-8588.
74. Navia, M. A. and Murcko, M. A. (1992) Use of structural information in drug design. Curr. Opin. struct. Biol. 2, 202-210.
75. Nicholls, A., Sharp, K. A. and Honig, B. H. (1991) Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296.
76. Nishibata, Y. and Itai, A. (1991) Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron 47, 8985-8990.
77. Nishibata, Y. and Itai, A. (1993) Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation. J. med. Chem. 36, 2921-2928.
78. Obst, U., Gramlich, V., Diederich, F., Weber, L. and Banner, D. W. (1995) Design of novel nonpeptidic thrombin inhibitors and structure of a thrombin-inhibitor complex. Angew. Chem. Int. Ed. 107, 1874-1877.
79. Oshiro, C. M., Kuntz, I. D. and Dixon, J. S. (1995) Flexible ligand docking using a genetic algorithm. J. Computer-aided Molec. Des. 9, 113-130.
80. Pearlman, D. A. and Murcko, M. A. (1996) CONCERTS: Dynamic connection of fragments as an approach to de novo ligand design. J. med. Chem. 39, 1651-1663.
81. Pisabarro, M. T., Ortiz, A. R., Palomer, A., Cabre, F., Garcia, L., Mauleon, D. and Carganico, G. (1994) Rational modification of human synovial fluid phospholipase A2 inhibitors. J. med. Chem. 37, 337-341.
82. Pisabarro, M. T. and Serrano, L. (1996) Rational design of specific high-affinity peptide ligands for the Ab1-SH3 domain. Biochemistry 35, 10,634-10,640.
83. Rao, B. G., Tilton, R. F. and Singh, U. C. (1992) Free energy pertubation studies on inhibitor binding to HIV-1 proteinase. J. Am. Chem. Soc. 114, 4447-4452.
84. Rarey, M., Wefing, S. and Lengauer, T. (1996) Placement of medium-sized fragments into active sites of proteins. J. Computer-aided Molec. Des. 10, 41-54.
85. Recanatini, M., Klein, T., Yang, C. Z., McClarin, J., Langridge, R. and Hansch, C. (1986) Quantitative structure-activity relationships and molecular graphics in ligand receptor interactions: Amidine inhibition of trypsin. Molec. Pharmac. 29, 436-446.
86. Reddy, M. R., Viswanadhan, V. N. and Weinstein, J. N. (1991) Relative differences in the biding free energies of human immunodeficiency virus 1 protease inhibitors: A thermodynamic cycle-pertubation approach. Proc. natn. Acad. Sci. U.S.A. 88, 10,287-10,291.
87. Ring, C. S., Sun, E., McKerrow, J. H., Lee, G. K., Rosenthal, P. J., Kuntz, I. D. and Cohen, F. E. (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc. natn. Acad. Sci. U.S.A. 90, 3583-3587.
88. Rotstein, S. H. and Murcko, M. A. (1993) Groupbuild: A fragment-based method for de novo drug design. J. med. Chem. 36, 1700-1710.
89. Sadowski, J., Rudolph, C. and Gasteiger, J. (1990) Automatic generation of 3D-atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 3, 537-547.
90. Schevitz, R. W., Bach, N. J., Carlson, D. G., Chirgadze, N. Y., Clawson, D. K., Dillard, R. D., Draheim, S. E., Hartley, L. W., Jones, N. D. and Mihelich, E. D. (1995) Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospolipase A2. Nature struct. Biol. 2, 458-465.
91. Shoichet, B. K., Stroud, R. M., Santi, D. V., Kuntz, I. D. and Perry, K. M. (1993) Structure-based discovery of inhibitors of thymidylate synthase. Science 259, 1445-1450.
92. Thaisrivongs, S., Watenpaugh, K. D., Howe, W. J., Tomich, P. K., Dolak, L. A., Chong, K. T., Tomich, C. C., Tomasselli, A. G., Turner, S. R. and Strohbach, J. W. (1995) Structure-based design of novel HIV protease inhibitors: Carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J. med. Chem. 38, 3624-3637.
93. Tschinke, V. and Cohen, N. C. (1993) The NEWLEAD program: A new method for the design of candidate structures from pharmacophoric hypotheses. J. med. Chem. 36, 3863-3870.
94. Van Gunsteren, W. F. and Weiner, P. K. (1989) Computer Simulations of Biomolecular Systems, Escom, Leiden.
95. Vara Prasad, J. V. N., Para, K. S., Lunney, E. A., Ortwine, D. F., Dunbar, J. B., Ferguson, D., Tummino, P. J., Hupe, D., Tait, B. D., Domagala, J. M., Humblet, C., Bhat, T. N., Liu, B., Guerin, D. M. A., Baldwin, E. T., Erickson, J. W. and Sawyer, T. K. (1994) Novel series of achiral, low molecular weight, and potent HIV-1 protease inhibitors. J. Am. Chem. Soc. 116, 6989-6990.
96. Varney, M. D., Palmer, C. L., Deal, J. G., Webber, S., Welsh, K. M., Bartlett, C. A., Morse, C. A., Smith, W. W.and Janson, C. A. (1995) J. med. Chem. 38, 1892-1903.
97. Verlinde, C. L. M. J. and Hol, W. G. J. (1994) Structure-based drug design: Progress, results and challenges. Structure 2, 577-587.
98. von Itzstein, M., Wu, W. Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Phan, T. V., Srnythe, M. L., White, H. F., Oliver, S. W., Colman, P. M., Varghese, J. N., Ryan, D. M., Woods, J. M., Bethell, R. C., Hothan, V. J., Cameron, J. M. and Penn, C. R. (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423.
99. Vajda, S., Weng, Z., Rosenfeld, R. and DeLisi, C. (1994) Effect of conformational flexibility and solvation on receptor-ligand binding free energies. Biochemistry 33, 13,977-13,988.
100. Wang, H. and Ben-Naim, A. (1996) A possible involvement of solvent-induced interactions in drug design. J. med. Chem. 39, 1531-1539.
101. Warshel, A., Tao, H., Fothergill, M. and Chu, Z. T. (1994) Effective methods for estimation of binding energies in computer-aided drug design. Isr. J. Chem. 34, 263-256.
102. Weber, L., Wallbaum, S., Broger, C. and Gubernator, K. (1995) Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm. Angew. Chem. Int. Ed. Engl. 34, 2280-2282.
103. Welch, W., Ruppert, J. and Jain, A. N. (1996) Hammerhead: Fast, fully automated docking of flexible ligands to protein binding sites. Chemistry and Biology 3, 449-462.
104. Williams, R. L., Vila, J., Perrot, G. and Scheraga, H. A. (1992) Empirical solvation models in the context of conformational energy searches: Application to bovine pancreatic trypsin inhibitor. Proteins 14, 110-119.
105. Wireko, F. C., Kellogg, G. E. and Abraham, D. J. (1991) Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors. J. med. Chem. 34, 758-767.
106. Wong, C. F. and McCammon, J. A. (1986) Dynamics and design of enzymes and inhibitors. J. Am. Chem. Soc. 108, 3830-3832.